Pawar Law Group Reminds Investors of NOV. 26 Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc. – MYGN
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit on behalf of shareholders who purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN) from September 2, 2016 through August 13, 2019 inclusive (the “Class …